Loading…
AdaptHealth Corp. is projected to rise to $12.56 by 2027, a +21% move from its current price of $10.36. AHCO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $10.14 | $10.36 | $10.59 | +0.03% |
| May 30 | $10.06 | $10.37 | $10.69 | +0.07% |
| May 31 | $9.99 | $10.37 | $10.76 | +0.10% |
| Jun 1 | $9.94 | $10.37 | $10.83 | +0.13% |
| Jun 2 | $9.89 | $10.38 | $10.89 | +0.16% |
| Jun 3 | $9.85 | $10.38 | $10.94 | +0.20% |
| Jun 4 | $9.81 | $10.38 | $10.99 | +0.23% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.81 | $10.38 | $10.99 | +0.23% |
| Week 2 | $9.60 | $10.41 | $11.28 | +0.46% |
| Week 3 | $9.45 | $10.43 | $11.51 | +0.69% |
| Week 4 | $9.33 | $10.46 | $11.71 | +0.92% |
| Week 5 | $9.23 | $10.48 | $11.90 | +1.15% |
| Week 6 | $9.14 | $10.50 | $12.07 | +1.39% |
| Week 7 | $9.06 | $10.53 | $12.23 | +1.62% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
AdaptHealth Corp. distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments.
The company offers sleep therapy equipment and services such as continuous positive airway pressure and BiLevel for obstructive sleep apnea; oxygen and home mechanical ventilation equipment and related chronic therapy services; and medical devices including continuous glucose monitors and insulin pumps for the treatment of diabetes. AdaptHealth also provides HME to patients discharged from acute care and other facilities, along with other HME devices and supplies.
AdaptHealth was founded in 2012 and is headquartered in Conshohocken, Pennsylvania. It services beneficiaries of Medicare, Medicaid, and commercial insurance payors.
AdaptHealth Corp. (AHCO) is a healthcare company with a current price of $10.45 per share and a market capitalization of $1.42B. It is ranked 2275 in market size.
The near-term technical picture remains bullish, with the RSI14 at 30 and key moving averages showing a tight setup: SMA50 at $11.68 and SMA200 at $10.14. Near-term support sits at $10.35 and resistance is at $13.38, framing a 30-day range of $8.99 to $12.14.
Forecasts project a path of upside over time. The 2026 average price is $10.45 with a max of $14.36. From 2027 onward, the averages rise toward $20.05 by 2030 and beyond, with higher maxes such as $28.24 by 2030, $71.13 by 2040, and $175.20 by 2050, alongside bullish sentiment through the period.
A major floor 19.6% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.1% away) — a key level to hold.
The nearest ceiling, 29.2% above — a clean break opens room to run.
A major ceiling 38.9% above — clearing it would confirm fresh momentum.
Key AHCO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AHCO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.44 | Sell | $10.44 | Sell |
| MA 10 | $10.55 | Sell | $10.66 | Sell |
| MA 20 | $11.33 | Sell | $11.08 | Sell |
| MA 50 | $11.67 | Sell | $11.30 | Sell |
| MA 100 | $10.88 | Sell | $10.97 | Sell |
| MA 200 | $10.15 | Buy | $10.48 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.80 | Neutral |
| Stoch RSI (14) | 14.45 | Buy |
| CCI (20) | -80.55 | Neutral |
| Williams %R (14) | -99.28 | Info |
| MACD (12,26,9) | -0.11 | Sell |
| ROC (12) | -8.32 | Sell |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 0.72 | Buy |
| TRIX (15) | -0.44 | Sell |
| Awesome (5,34) | -1.43 | Sell |
| Ultimate (7,14,28) | 29.49 | Buy |
| Momentum (10) | -0.89 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 10.35 | Buy |
| ADX (14) | 31.81 | Sell |
| ATR (14) | 0.18 | Info |
The 30-day picture shows bullish sentiment with a current RSI of 30. The stock trades around key moving averages, with the SMA50 at $11.68 and the SMA200 at $10.14.
Near-term support is $10.35 and resistance is $13.38, placing the 30-day range between $8.99 and $12.14. These levels help frame potential near-term risk and upside potential within a tight band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.85 | $10.36 | $14.10 | 0% | Neutral | |
| $10.16 | $12.56 | $16.30 | +21% | Bullish | |
| $11.90 | $15.01 | $20.06 | +45% | Bullish | |
| $14.58 | $18.71 | $25.59 | +81% | Bullish | |
| $15.16 | $19.76 | $27.56 | +91% | Bullish | |
| $15.91 | $21.02 | $29.82 | +103% | Bullish | |
| $17.39 | $23.28 | $33.55 | +125% | Bullish | |
| $17.88 | $24.22 | $35.40 | +134% | Bullish | |
| $19.27 | $26.41 | $39.10 | +155% | Bullish | |
| $22.13 | $30.66 | $45.96 | +196% | Bullish | |
| $29.76 | $43.32 | $68.35 | +318% | Bullish | |
| $62.04 | $98.06 | $166.94 | +847% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $8.85 | $10.36 | $12.19 | +0.00% |
| June 2026 | $9.12 | $10.67 | $12.73 | +2.95% |
| July 2026 | $9.07 | $10.67 | $12.87 | +0.09% |
| August 2026 | $9.28 | $10.97 | $13.34 | +2.78% |
| September 2026 | $9.56 | $11.36 | $13.90 | +3.51% |
| October 2026 | $9.47 | $11.29 | $13.91 | -0.53% |
| November 2026 | $9.31 | $11.14 | $13.79 | -1.41% |
| December 2026 | $9.44 | $11.33 | $14.10 | +1.73% |
Click any year to see its month-by-month AHCO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, AHCO is projected to trade between $8.85 and $14.10, averaging $10.36 — a potential gain of 0% from today's $10.36. Price action looks broadly range-bound.
AdaptHealth Corp.'s 2027 outlook centres on $12.56, within a $10.16 to $16.30 range. That is up +21% on the projected 2026 average. That marks a +21% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, AHCO could reach as high as $20.06, with a base case around $15.01 and support toward $11.90 — roughly +45% from $10.36. Momentum favours further upside here.
Expect AHCO to range from $14.58 to $25.59 through 2029. The $18.71 average target implies a +81% move from current prices. That is up +25% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The AHCO price prediction for 2030 points to an average of $19.76 (low $15.16, high $27.56) — a potential gain of +91% on today's $10.36. Momentum favours further upside here.
In 2031, AHCO is projected to trade between $15.91 and $29.82, averaging $21.02 — a potential gain of +103% from today's $10.36. That is up +6% on the projected 2030 average. Buyers look set to stay in control over this stretch.
AdaptHealth Corp.'s 2032 outlook centres on $23.28, within a $17.39 to $33.55 range. That is up +11% on the projected 2031 average. That marks a +125% change versus current levels. Momentum favours further upside here.
By 2033, AHCO could reach as high as $35.40, with a base case around $24.22 and support toward $17.88 — roughly +134% from $10.36. Buyers look set to stay in control over this stretch.
Expect AHCO to range from $19.27 to $39.10 through 2034. The $26.41 average target implies a +155% move from current prices. That is up +9% on the projected 2033 average. Momentum favours further upside here.
The AHCO price prediction for 2035 points to an average of $30.66 (low $22.13, high $45.96) — a potential gain of +196% on today's $10.36. Buyers look set to stay in control over this stretch.
In 2040, AHCO is projected to trade between $29.76 and $68.35, averaging $43.32 — a potential gain of +318% from today's $10.36. That is up +41% on the projected 2035 average. Momentum favours further upside here.
AdaptHealth Corp.'s 2050 outlook centres on $98.06, within a $62.04 to $166.94 range. That is up +126% on the projected 2040 average. That marks a +847% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in AHCO today (≈ 96.525097 AHCO) could be worth
$9,464.99
+$8,464.99 (+846%) by 2050 · US Dollar
Based on the average projected AHCO price of $98.06 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AHCOwould be worth at today's price.
$1,000 invested in AHCO on May 27, 2025 (≈ 107.411381 AHCO) would be worth
$1,112.78
+$112.78 (+11.3%) today · 1.11× · US Dollar
Based on a AHCO entry price of $9.31 vs. today's $10.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.48 | $988.55 | -1.1% |
| 1 month ago | $13.08 | $792.05 | -20.8% |
| 3 months ago | $9.08 | $1,140.97 | +14.1% |
| 6 months ago | $9.66 | $1,072.46 | +7.2% |
| 1 year ago | $9.31 | $1,112.78 | +11.3% |
| All time (5.0y) ago | $25.7 | $403.11 | -59.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AHCO forecast.
Our base-case forecast reaches $21.00 around 2031.
Implied market cap at $21.00: $2.86B
The multi-year forecast points to substantial upside. In 2030, the average price is projected to be $20.05, with a max of $28.24 and a minimum of $15.26, for an estimated ROI of 91.8% and a bullish sentiment.
Going further, 2040 carries an average of $44.36 and a max of $71.13, with an ROI of 324.5% and bullish sentiment. By 2050, the forecast shows an average of $100.96 and a max of $175.20, with an ROI of 866.1% and bullish sentiment. The 2026 figure sits at an average of $10.45 with an ROI of 0 and neutral sentiment.
The forecast implies strong upside through the period, but it also notes notable volatility, with an annualized volatility of 40%, indicating pronounced risk alongside the upside.
Tap a question to reveal the answer.
In 2030 the forecast shows an average price of $20.05 with a max of $28.24 and a min of $15.26, and an estimated ROI of 91.8%, with bullish sentiment.
Forecasts show bullish sentiment from 2027 onward, with rising averages and ROI: 2027 avg $12.70, ROI 21.5; 2028 avg $15.28, ROI 46.2; 2029 avg $19.16, ROI 83.3; 2030 avg $20.05, ROI 91.8; and 2050 avg $100.96, ROI 866.1, while 2026 is neutral with avg $10.45 and ROI 0.
The forecast’s max prices show $50+ later in the timeline: max $71.13 in 2040 and max $175.20 in 2050, with the 2035 max at $47.95. This indicates the possibility of surpassing $50 by 2040 and more strongly by 2050.
Current price is $10.45 and the market cap is $1.42B, with a rank of 2275.
RSI14 is 30. The 30-day picture features SMA50 at $11.68 and SMA200 at $10.14, with near-term support at $10.35 and resistance at $13.38. The 30-day range runs from $8.99 to $12.14, and annualized volatility is 40%.
AdaptHealth Corp. Community Discussion
0Share your AdaptHealth Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.